Executive Summary
This morning's 50 filings present a bifurcated market landscape. A dominant theme is the concentrated, passive accumulation of shares in a single micro-cap, Park Ha Biological Technology, by six separate entities, collectively amassing over 56% of the diluted float, signaling a potential strategic play or a prelude to a corporate action.
This is contrasted by significant insider selling, with a director at Spyre Therapeutics cashing out over $1M in a 10b5-1 plan and a 10% owner at Ramaco Resources liquidating a $4.8M stake. The healthcare sector shows a mixed picture: while Aptevo Therapeutics saw broad-based insider option exercises (a neutral-to-bullish signal of confidence), a director at Bausch & Lomb sold shares. On the capital allocation front, the Apollo-managed funds disclosed massive, stable stakes in Phoenix Education (69.1%) and Community Health Systems (8.4%), indicating a long-term, hands-off approach. The most critical development is the complete change of control at Abits Group, where the CEO sold his 47% voting stake, creating a binary catalyst tied to a future business acquisition. Overall, the data suggests a market where large institutional players are making strategic bets in small-cap biotech and distressed sectors, while insiders in high-growth and cyclical names are taking profits.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13G · Form 4 · Schedule 13D
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from August 10, 2026.
Investment Signals (10)
- Spyre Therapeutics ↓ (BEARISH)▲
Director Albers sold $1.05M in stock at ~$104.68, executing a 10b5-1 plan. This is a significant insider sale at a high valuation, suggesting the stock may be near a peak or the insider is de-risking.
- Ramaco Resources ↓ (BEARISH)▲
A 10% owner sold 500,000 shares for $4.79M at $9.57. This is a large, open-market sale by a major holder, signaling a potential lack of confidence in near-term coal price or company prospects.
-
Six separate entities filed 13Gs, collectively owning 56.1% of the diluted shares. This extreme concentration of ownership in a micro-cap post-reverse split is a strong signal of a potential going-private transaction, strategic investment, or future merger. [BULLISH for a takeout premium]
- Aptevo Therapeutics ↓ (BULLISH)▲
The CEO, CFO, and multiple directors exercised stock options/RSUs, converting them to common stock. This is a classic bullish signal, as insiders are putting their own capital at risk and increasing their equity exposure.
-
The CEO and Chairman sold his entire 47% stake to ARC Group International, with a contingent right to receive $5M in shares or cash. This is a massive change in control, creating a high-risk, high-reward scenario tied to a 180-day business acquisition deadline. [BULLISH if acquisition is value-accretive, BEARISH if not]
- Procter & Gamble ↓ (BULLISH)▲
The CEO of the Beauty division was awarded restricted stock units. This is a standard equity grant, but it aligns management's interests with long-term shareholder value and is a neutral-to-positive signal for the company's largest division.
- Jewett Cameron Trading ↓ (BULLISH)▲
A director purchased $326K in stock via an 'Obligation to Buy' and a purchase option. This is a very bullish signal, as a director is making a substantial personal investment in a small-cap company, indicating strong conviction in its future.
-
A director (Simanovsky) exercised a massive 1.5M shares at $32.00, a $48.1M transaction, then disposed of them to the issuer. This is a complex signal; the exercise shows confidence, but the immediate disposal suggests a capital restructuring or a desire to monetize, not a long-term hold. [NEUTRAL/BEARISH]
- Grupo Aeromexico ↓ (NEUTRAL)▲
Apollo entities disclosed a stable 18.9% stake with no change from prior filing. This is a neutral signal of a long-term, passive hold in a post-restructuring airline, indicating no near-term catalyst from this holder.
- Bausch & Lomb ↓ (BEARISH)▲
A director sold ~$306K worth of shares. While not a massive sale, it is a negative signal from a director at a company that has been under financial pressure.
Risk Flags (8)
- ▼
Six entities hold 56.1% of the diluted shares. This extreme concentration creates a liquidity risk for minority shareholders and a high risk of price manipulation or a dilutive event.
- Abits Group / Change of Control↓ [HIGH RISK]▼
The CEO sold his entire 47% stake. The new owner's intentions are unknown, and the company's future is tied to a 180-day business acquisition. If the acquisition fails, the company faces a $5M cash liability.
- Ramaco Resources / Insider Selling↓ [MEDIUM RISK]▼
A 10% owner sold a $4.79M stake. This is a strong negative signal for a cyclical company, suggesting the holder believes the stock is fully valued or that industry headwinds are building.
- Spyre Therapeutics / Insider Selling↓ [MEDIUM RISK]▼
A director sold over $1M in stock via a 10b5-1 plan. While pre-planned, the magnitude of the sale at a high stock price raises a red flag about valuation and insider sentiment.
- Bausch & Lomb / Insider Selling↓ [MEDIUM RISK]▼
A director sold shares, adding to a pattern of insider selling at the company. This is a concern for a company with a high debt load and ongoing restructuring.
- Red Rock Resorts / Insider Tax Withholding↓ [LOW RISK]▼
The President had 143,841 shares withheld for taxes, valued at $8.91M. While a standard practice, the sheer size of the withholding (over 40% of his holdings) indicates a massive tax event and reduces his alignment with shareholders.
- Community Health Systems / High Debt, Passive Holders↓ [MEDIUM RISK]▼
Apollo's 8.4% stake is passive. The company operates with high leverage, and the lack of activist pressure from a major holder could mean a slower turnaround.
- Central Pacific Financial / CEO Gifting↓ [LOW RISK]▼
The Chairman, President & CEO gifted 2,750 shares. While not a sale, gifting can be a prelude to selling or a signal of estate planning, but it reduces the insider's direct economic exposure.
Opportunities (8)
- ◆
With six entities holding 56.1% of the diluted shares, the company is a prime candidate for a going-private transaction or a strategic merger. The post-reverse stock split structure makes it a clean vehicle.
- Aptevo Therapeutics / Insider Confidence↓ (OPPORTUNITY)◆
The CEO, CFO, and multiple directors exercised options to acquire common stock. This is a strong vote of confidence from management in a small-cap biotech, suggesting they believe the stock is undervalued.
- Jewett Cameron Trading / Director Conviction↓ (OPPORTUNITY)◆
A director invested $326K in a small-cap company. This is a high-conviction insider buy that often precedes positive developments or a re-rating.
- Abits Group / Binary Catalyst (180-Day Acquisition)↓ (OPPORTUNITY)◆
The new controlling shareholder has a 180-day window to complete a 'Business Acquisition.' If successful, the CEO's contingent $5M payment in shares could be a powerful catalyst. This is a high-risk, high-reward event-driven play.
- Sonida Senior Living / Director Exercise at $32↓ (OPPORTUNITY)◆
A director exercised 1.5M shares at $32.00, implying a belief that the stock is worth more than that. The subsequent disposal to the issuer could be a precursor to a capital return or a buyout.
- Phoenix Education Partners / Apollo's 69.1% Stake↓ (OPPORTUNITY)◆
Apollo's massive, stable stake suggests a long-term view. The company could be a candidate for a take-private or a major strategic shift, offering a potential premium for minority holders.
- Procter & Gamble / Beauty Division CEO Award↓ (OPPORTUNITY)◆
The RSU award to the Beauty CEO aligns him with performance. P&G's Beauty division is a key growth driver, and this incentive could lead to outperformance.
-
While a sale, the fact that it was pre-planned under a 10b5-1 plan removes some of the negative stigma. The stock is at a low price, and the sale was small relative to holdings, suggesting it is not a panic move. [OPPORTUNITY for contrarians]
Sector Themes (5)
- Micro-Cap Concentration & Strategic Accumulation◆
The most striking theme is the coordinated accumulation of Park Ha Biological Technology by six entities, collectively owning over 56% of the diluted float. This pattern suggests a strategic play, likely a precursor to a merger, buyout, or reverse merger, and is a high-risk, high-reward theme for event-driven investors.
- Healthcare Insider Divergence◆
The healthcare sector shows a clear divergence. On one hand, Aptevo Therapeutics insiders are exercising options and buying stock, signaling confidence. On the other, Bausch & Lomb and Spyre Therapeutics directors are selling, indicating a lack of conviction or a desire to take profits. This suggests a stock-picker's market within healthcare.
- Apollo's Passive, Long-Term Holdings◆
Apollo Management entities disclosed large, stable, passive stakes in Community Health Systems (8.4%), Grupo Aeromexico (18.9%), and Phoenix Education (69.1%). This pattern indicates a strategy of making large, illiquid investments in distressed or special situations and holding for the long term, rather than seeking a quick exit.
- Goldman Sachs' Broad, Passive SPAC Exposure◆
Goldman Sachs filed 13Gs for multiple SPACs (Peace Acquisition, HCM IV, FACT II, Cal Redwood, Energy Transition Special Opportunities). This is a routine disclosure of a large investment bank's market-making and passive holdings, but it highlights the ongoing, albeit diminished, activity in the SPAC market.
- Insider Profit-Taking in Cyclicals◆
The sale by a 10% owner of Ramaco Resources (coal) and the large tax-withholding sale by the President of Red Rock Resorts (gaming) suggest that insiders in cyclical sectors are taking profits or reducing exposure, potentially signaling a belief that the cycle is peaking.
Watch List (7)
-
The new controlling shareholder must complete a 'Business Acquisition' by February 2027 or pay $5M. Watch for any announcements of a target or deal structure. This is a key binary event.
-
Given the concentrated ownership, watch for any entity to file a Schedule 13D, which would signal activist intent or a formal takeover bid. The reverse stock split date (Aug 6, 2026) is a key reference point.
-
After a director sold $1M, watch for other insiders to follow suit. A pattern of selling would be a strong bearish signal for the stock.
-
The director's exercise and disposal of 1.5M shares to the issuer could be a precursor to a tender offer, a special dividend, or a buyout. Watch for any corporate action announcements.
-
With insiders loading up on stock, watch for any clinical trial results, partnership announcements, or financing news that could be the catalyst for their confidence.
-
Apollo's 8.4% passive stake is large. Watch for any change in filing status (to 13D) or public statements that could signal a shift to a more active role, such as pushing for asset sales or a restructuring.
-
After a 10% owner sold a large block, watch for any additional sales by other insiders. This could indicate a broader lack of confidence in the coal sector's near-term outlook.
Filing Analyses
(50)
10-08-2026
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G with the SEC on August 10, 2026, disclosing beneficial ownership of approximately 8,022,497 shares of Leggett & Platt, Inc. common stock, representing a 5.9% stake as of June 30, 2026. The filing is made under Rule 13d-1(b) and states the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and is a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the entities.
- · The beneficial ownership excludes certain client accounts and investment entities where Goldman Sachs acts as general partner or manager, to the extent interests are held by others.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G with the SEC on August 10, 2026, disclosing beneficial ownership of 3,395,845 ordinary shares of monday.com Ltd., representing 6.6% of the company's outstanding shares as of June 30, 2026. The filing indicates that Goldman Sachs holds the shares in the ordinary course of business and not for the purpose of changing or influencing control of monday.com.
- · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934, indicating passive investment intent.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and is a subsidiary of The Goldman Sachs Group, Inc.
- · The Goldman Sachs Reporting Units disclaim beneficial ownership of securities held in client accounts or certain investment entities where they act as general partner or manager.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of Goldman Sachs.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G with the SEC on August 10, 2026, disclosing a 6.2% beneficial ownership stake in Peace Acquisition Corp., a blank-check company. As of June 30, 2026, the entities hold 545,205 ordinary shares (par value $0.0001 per share). The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- · The beneficial ownership is reported under Rule 13d-1(b) as of June 30, 2026.
- · Goldman Sachs disclaims beneficial ownership of securities in client accounts and certain investment entities where it acts as general partner.
- · The filing includes powers of attorney for multiple officers to sign future filings through July 2027.
- · No prior period comparison available as the filing does not include historical ownership data.
10-08-2026
Director VON ESCHENBACH ANDREW C. sold 12,500 Common Shares, No Par Value at $16.50 (~$206K). VON ESCHENBACH ANDREW C. holds 63,733 shares after the transaction.
- · Director VON ESCHENBACH ANDREW C. sold 12,500 Common Shares, No Par Value at $16.50 (~$206K)
- · Director VON ESCHENBACH ANDREW C. sold 6,059 Common Shares, No Par Value at $16.58 (~$100K)
10-08-2026
Director Binder Steven B. sold 39,051 Common Stock, $0.01 Par Value at $4.06 (~$159K). Binder Steven B. holds 785,867 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Binder Steven B. sold 39,051 Common Stock, $0.01 Par Value at $4.06 (~$159K)
10-08-2026
PenderFund Capital Management Ltd. filed a Schedule 13G with the SEC on August 10, 2026, disclosing beneficial ownership of 6,363,048 shares of General Fusion Group Ltd. (formerly Spring Valley Acquisition Corp. III), representing 9.97% of the outstanding common stock. The filing is a routine institutional ownership disclosure under Rule 13d-1(b), indicating passive investment intent without control influence.
- · The filing is a Schedule 13G (passive investment) rather than a 13D (activist filing).
- · PenderFund Capital Management Ltd. is a Canadian institutional investment manager based in Vancouver, BC.
- · The issuer changed its name from Spring Valley Acquisition Corp. III to General Fusion Group Ltd. on June 26, 2026.
- · All 6,363,048 shares are held directly by PenderFund with sole voting and dispositive power.
- · The filing certifies the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.
10-08-2026
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G with the SEC on August 10, 2026, disclosing beneficial ownership of 1,485,647 Class A Ordinary Shares of HCM IV Acquisition Corp. (a blank-check company formerly known as Mercator I Acquisition Corp.), representing 5.2% of the outstanding shares. The filing is made under Rule 13d-1(b) and certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- · The filing is made under Rule 13d-1(b), indicating the shares are held in the ordinary course of business and not for control purposes.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and is a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the entities.
- · The issuer, HCM IV Acquisition Corp., is a blank-check company (SIC 6770) incorporated in the Cayman Islands (E9) and changed its name from Mercator I Acquisition Corp. on October 2, 2025.
10-08-2026
10% owner DISCOVERY CAPITAL MANAGEMENT, LLC / CT sold 500,000 Class A Common Stock, $0.01 par value at $9.57 (~$4.79M). DISCOVERY CAPITAL MANAGEMENT, LLC / CT holds 4,811,360 shares after the transaction.
- · 10% owner DISCOVERY CAPITAL MANAGEMENT, LLC / CT sold 500,000 Class A Common Stock, $0.01 par value at $9.57 (~$4.79M)
10-08-2026
CEO - Beauty Bharucha Freddy P. was awarded 7.0899 Restricted Stock Units. 6 transactions reported in total.
- · CEO - Beauty Bharucha Freddy P. was awarded 7.0899 Restricted Stock Units
- · CEO - Beauty Bharucha Freddy P. was awarded 6.2185 Restricted Stock Units
- · CEO - Beauty Bharucha Freddy P. was awarded 7.273 Restricted Stock Units
- · CEO - Beauty Bharucha Freddy P. was awarded 0.3148 Series A Preferred Stock
- · CEO - Beauty Bharucha Freddy P. was awarded 0.2445 Series A Preferred Stock
- · CEO - Beauty Bharucha Freddy P. was awarded 789 Restricted Stock Units
10-08-2026
Pinnacle International Holding Limited and Yajie Ma filed a Schedule 13G with the SEC on August 10, 2026, disclosing beneficial ownership of 325,000 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 7.6% of the outstanding shares (based on 2,297,902 shares outstanding post-reverse stock split on August 6, 2026, plus 2,000,000 shares underlying exercisable warrants). The filing indicates the shares were acquired in the ordinary course of business and not to influence control.
- · Each reporting person beneficially owns 325,000 Class A Ordinary Shares, including 200,000 shares underlying warrants exercisable within 60 days.
- · Ownership percentage of 7.6% is based on 2,297,902 shares outstanding after reverse stock split on August 6, 2026, plus 2,000,000 shares underlying warrants exercisable within 60 days.
- · The filing is made under Rule 13d-1(c), indicating passive investment intent.
10-08-2026
Nexera Technology Company Limited and Jie Cao filed a Schedule 13G with the SEC on August 10, 2026, reporting beneficial ownership of 390,000 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 9.1% of the outstanding shares. The filing includes 240,000 shares issuable upon exercise of warrants within 60 days. The ownership percentage is based on 2,297,902 shares outstanding after a reverse stock split on August 6, 2026, plus 2,000,000 shares underlying a warrant exercisable within 60 days.
- · Filing type: Schedule 13G (passive investment, not for control)
- · Reporting persons: Nexera Technology Company Limited and Jie Cao
- · Address: Room 301, No. 10 Erquan Dongyuan, Wuxi City, Jiangsu Province, China
- · Issuer: Park Ha Biological Technology Co., Ltd., based in Wuxi, Jiangsu Province, China
- · Security: Class A Ordinary Shares, par value $0.008 per share
- · Reverse stock split effective August 6, 2026
- · Warrant for 2,000,000 shares exercisable within 60 days
- · Certification: securities not acquired to change or influence control
10-08-2026
Velociti Group Limited and Chunxin Xia filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 9.8% of the outstanding shares. The filing was made under Rule 13d-1(c) and is dated August 10, 2026. The ownership percentage is calculated based on 2,297,902 Class A Ordinary Shares outstanding after a reverse stock split on August 6, 2026, plus 2,000,000 shares underlying a warrant exercisable within 60 days.
- · The filing is a Schedule 13G (passive investment, not an activist filing) under Rule 13d-1(c).
- · The beneficial ownership includes 260,000 shares underlying warrants exercisable within 60 days.
- · The percentage calculation also includes 2,000,000 shares underlying a separate warrant exercisable within 60 days.
- · The company underwent a reverse stock split effective August 6, 2026, reducing outstanding shares to 2,297,902.
- · The reporting persons certify the securities were not acquired to change or influence control of the issuer.
10-08-2026
On August 10, 2026, Rove Trading Co., Limited and its director Yingying Guo filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 9.8% of the outstanding shares. The filing was made under Rule 13d-1(c) and certifies that the securities were not acquired to change or influence control of the issuer.
- · The filing is a Schedule 13G (not 13D), indicating passive investment intent.
- · The beneficial ownership includes 260,000 shares underlying warrants exercisable within 60 days.
- · The denominator for percentage calculation includes 2,000,000 shares underlying a separate warrant exercisable within 60 days.
- · The company underwent a reverse stock split effective August 6, 2026, reducing outstanding shares to 2,297,902.
- · The reporting persons certify the securities were not acquired to change or influence control of the issuer.
10-08-2026
Peverel Summit Holdings Limited and Qi Meng filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares (9.8%) of Park Ha Biological Technology Co., Ltd., including 260,000 shares from warrants exercisable within 60 days. The filing is passive (Rule 13d-1(c)) and follows a reverse stock split effective August 6, 2026, which reduced the share count to 2,297,902 outstanding shares. The ownership percentage is based on a diluted share count that includes 2,000,000 shares underlying a warrant exercisable within 60 days.
- · The filing is made under Rule 13d-1(c), indicating passive investment intent.
- · The reverse stock split became effective on August 6, 2026, reducing outstanding shares to 2,297,902.
- · The ownership percentage calculation includes 2,000,000 shares from a warrant exercisable within 60 days, which significantly dilutes the percentage.
- · The reporting persons certify that the securities were not acquired to change or influence control of the issuer.
10-08-2026
Corin Global Partners Holdings Limited and its director Ng Yee Loon filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 9.8% of the outstanding shares. The filing was made under Rule 13d-1(c) and certifies the shares were not acquired to change or influence control of the issuer. The ownership percentage is calculated based on 2,297,902 Class A Ordinary Shares outstanding after an August 6, 2026 reverse stock split, plus 2,000,000 shares underlying a warrant exercisable within 60 days.
- · The filing is a Schedule 13G (not 13D), indicating passive investment intent.
- · The beneficial ownership includes 260,000 shares from warrants exercisable within 60 days.
- · The ownership percentage denominator includes 2,000,000 shares underlying a separate warrant exercisable within 60 days.
- · A reverse stock split was effective on August 6, 2026, reducing the outstanding share count to 2,297,902.
- · The reporting persons certify the shares were not acquired to change or influence control of the issuer.
10-08-2026
On August 10, 2026, Fusen Advertising Design Limited and its sole director, Hao Meng (Mike), filed a Schedule 13G disclosing beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological Technology Co., Ltd., representing 9.8% of the outstanding shares. The filing is a passive investment disclosure under Rule 13d-1(c), and the reported ownership includes 260,000 shares underlying warrants exercisable within 60 days. The percentage is calculated based on 2,297,902 Class A shares outstanding after a reverse stock split on August 6, 2026, plus 2,000,000 shares underlying a warrant exercisable within 60 days.
- · The filing is a Schedule 13G (passive investment) under Rule 13d-1(c), indicating the shares were not acquired to change or influence control of the issuer.
- · The beneficial ownership includes 260,000 Class A Ordinary Shares for which warrants are exercisable within 60 days.
- · The ownership percentage is based on 2,297,902 Class A shares outstanding after a reverse stock split on August 6, 2026, plus 2,000,000 shares underlying a warrant exercisable within 60 days.
- · Fusen Advertising Design Limited and Hao Meng each report the same number of shares (422,500) and the same percentage (9.8%), suggesting Hao Meng controls Fusen Advertising Design Limited.
10-08-2026
SVP, CFO McNulty Matthew J had withheld for taxes 239 Common Stock at $23.51 (~$5.62K). McNulty Matthew J holds 19,245 shares after the transaction.
- · SVP, CFO McNulty Matthew J had withheld for taxes 239 Common Stock at $23.51 (~$5.62K)
10-08-2026
EVP, Retail Division Phillips Amy had withheld for taxes 417 Common Stock at $23.51 (~$9.8K). Phillips Amy holds 22,477 shares after the transaction.
- · EVP, Retail Division Phillips Amy had withheld for taxes 417 Common Stock at $23.51 (~$9.8K)
10-08-2026
Chairman, President & CEO Martines Arnold D gifted 2,750 Common Stock. Martines Arnold D holds 3,940 shares after the transaction.
- · Chairman, President & CEO Martines Arnold D gifted 2,750 Common Stock
10-08-2026
Chairman, President & CEO KATHWARI M FAROOQ had withheld for taxes 3,272 Common Stock at $23.51 (~$76.9K). KATHWARI M FAROOQ holds 1,488,341 shares after the transaction.
- · Chairman, President & CEO KATHWARI M FAROOQ had withheld for taxes 3,272 Common Stock at $23.51 (~$76.9K)
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 4,312,980.20 shares of ETSY Inc. common stock as of June 30, 2026, representing 4.5% of the company's outstanding shares. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of ETSY. This is a routine disclosure of passive investment, with no indication of any change in investment intent or control.
- · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b), indicating passive investment.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney dated July 8, 2026 and July 2, 2026.
- · The beneficial ownership is reported as of June 30, 2026, with the filing date of August 10, 2026.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G/A disclosing beneficial ownership of 756,137 Class A ordinary shares of FACT II Acquisition Corp., representing 4.1% of the outstanding shares as of June 30, 2026. The filing is an amendment to a previous Schedule 13G and indicates the shares are held in the ordinary course of business, not for changing or influencing control of the issuer.
- · The filing is an amendment (Schedule 13G/A) filed on August 10, 2026, with an as-of date of June 30, 2026.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the entities.
- · The beneficial ownership is reported under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.
10-08-2026
Director Niederhuber John exercised/converted 400 Common Stock. Niederhuber John holds 400 shares after the transaction.
- · Director Niederhuber John exercised/converted 400 Common Stock
- · Director Niederhuber John exercised/converted 400 Restricted Stock Unit
10-08-2026
Director BUSQUET ANNE exercised/converted 7,500 Common Stock. BUSQUET ANNE holds 308,888 shares after the transaction.
- · Director BUSQUET ANNE exercised/converted 7,500 Common Stock
- · Director BUSQUET ANNE exercised/converted 7,500 Restricted Stock Unit
10-08-2026
Director KORN BILL exercised/converted 7,500 Common Stock. KORN BILL holds 225,383 shares after the transaction.
- · Director KORN BILL exercised/converted 7,500 Common Stock
- · Director KORN BILL exercised/converted 7,500 Restricted Stock Unit
10-08-2026
Director MUNTER CAMERON exercised/converted 7,500 Common Stock. MUNTER CAMERON holds 216,500 shares after the transaction.
- · Director MUNTER CAMERON exercised/converted 7,500 Common Stock
- · Director MUNTER CAMERON exercised/converted 7,500 Restricted Stock Unit
10-08-2026
Director Sharnak Lawrence Steven exercised/converted 7,500 Common Stock. Sharnak Lawrence Steven holds 141,500 shares after the transaction.
- · Director Sharnak Lawrence Steven exercised/converted 7,500 Common Stock
- · Director Sharnak Lawrence Steven exercised/converted 7,500 Restricted Stock Unit
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC, reporting beneficial ownership of approximately 1,531,065 shares of Delek US Holdings, Inc. common stock as of June 30, 2026. This represents a 2.5% stake in the company. The filing is a routine disclosure of passive ownership and does not indicate any change in control intent.
- · The filing is an amendment (SC 13G/A) to a previous Schedule 13G.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and a subsidiary of Goldman Sachs Group Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the entities.
- · The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Delek US Holdings.
10-08-2026
Conversant Capital LLC and affiliated entities filed Amendment No. 9 to their Schedule 13D, disclosing aggregate beneficial ownership of 15,637,124 shares (including 1,031,250 shares issuable upon exercise of warrants) of Sonida Senior Living, Inc., representing 32.3% of the company's outstanding common stock. The filing updates ownership stakes for multiple Conversant investment vehicles, with Conversant Capital LLC being the largest single filer at 32.3% and Michael Simanovsky also reporting 32.3% beneficial ownership. No period-over-period comparisons are available as this is an ownership snapshot amendment.
- · This is Amendment No. 9 to the original Schedule 13D filed on November 12, 2021.
- · The filing was made pursuant to Rule 13d-1(a) under the Securities Exchange Act of 1934.
- · Conversant Capital LLC serves as the investment manager for all Conversant Investors.
- · Conversant GP Holdings LLC is the general partner of Investor A, B, D, and F.
- · Conversant Private GP LLC is the general partner of Aggregator A, CPIF K, and CPIF SAF.
- · The Reporting Persons may constitute a 'group' under Section 13(d)(3) of the Exchange Act.
- · Each Conversant Investor expressly disclaims beneficial ownership of shares held by other Reporting Persons.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G disclosing beneficial ownership of 836,796 Class A ordinary shares of Energy Transition Special Opportunities (formerly Climate Transition Special Opportunities SPAC I), representing a 5.6% stake as of June 30, 2026. The filing is a routine disclosure of a passive, non-control investment by a major financial institution. No period-over-period comparisons are available as this is an initial filing.
- · The filing is made under Rule 13d-1(b), indicating a passive investment not intended to influence control.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser.
- · The company changed its name from Climate Transition Special Opportunities SPAC I to Energy Transition Special Opportunities on September 15, 2025.
- · The filing date is August 10, 2026, with the ownership snapshot as of June 30, 2026.
10-08-2026
Director Harsanyi Zsolt exercised/converted 400 Common Stock. Harsanyi Zsolt holds 400 shares after the transaction.
- · Director Harsanyi Zsolt exercised/converted 400 Common Stock
- · Director Harsanyi Zsolt exercised/converted 400 Restricted Stock Unit
10-08-2026
President and CEO Lamothe Jeffrey G. exercised/converted 961 Common Stock. Lamothe Jeffrey G. holds 961 shares after the transaction.
- · President and CEO Lamothe Jeffrey G. exercised/converted 961 Common Stock
- · President and CEO Lamothe Jeffrey G. exercised/converted 961 Restricted Stock Unit
10-08-2026
SVP, CFO Taylor Daphne exercised/converted 638 Common Stock. Taylor Daphne holds 638 shares after the transaction.
- · SVP, CFO Taylor Daphne exercised/converted 638 Common Stock
- · SVP, CFO Taylor Daphne exercised/converted 638 Restricted Stock Unit
10-08-2026
SVP, GC, BD & Corp Affairs Kwon SoYoung exercised/converted 638 Common Stock. Kwon SoYoung holds 638 shares after the transaction.
- · SVP, GC, BD & Corp Affairs Kwon SoYoung exercised/converted 638 Common Stock
- · SVP, GC, BD & Corp Affairs Kwon SoYoung exercised/converted 638 Restricted Stock Unit
10-08-2026
Director Simanovsky Michael exercised/converted 1,504,134 Common Stock at $32.00 (~$48.1M). 12 transactions reported in total. Simanovsky Michael holds 807,115 shares after the transaction.
- · Director Simanovsky Michael disposed to the issuer 1,504,134 Common Stock
- · Director Simanovsky Michael disposed to the issuer 97,371 Common Stock
- · Director Simanovsky Michael exercised/converted 1,504,134 Common Stock at $32.00 (~$48.1M)
- · Director Simanovsky Michael exercised/converted 97,371 Common Stock at $32.00 (~$3.12M)
- · Director Simanovsky Michael was awarded 38,742 Series A Convertible Preferred Stock
- · Director Simanovsky Michael was awarded 2,508 Series A Convertible Preferred Stock
- · Director Simanovsky Michael disposed to the issuer 38,742 Series A Convertible Preferred Stock
- · Director Simanovsky Michael disposed to the issuer 2,508 Series A Convertible Preferred Stock
10-08-2026
SVP, CMO Huebner Dirk had withheld for taxes 156 Common Stock at $4.07 (~$635). Huebner Dirk holds 482 shares after the transaction.
- · SVP, CMO Huebner Dirk exercised/converted 638 Common Stock
- · SVP, CMO Huebner Dirk had withheld for taxes 156 Common Stock at $4.07 (~$635)
- · SVP, CMO Huebner Dirk exercised/converted 638 Restricted Stock Unit
10-08-2026
Director Grant Grady III exercised/converted 400 Common Stock. Grant Grady III holds 1,150 shares after the transaction.
- · Director Grant Grady III exercised/converted 400 Common Stock
- · Director Grant Grady III exercised/converted 400 Restricted Stock Unit
10-08-2026
Executive Chair White Marvin L had withheld for taxes 406 Common Stock at $4.07 (~$1.65K). 5 transactions reported in total. White Marvin L holds 1,261 shares after the transaction.
- · Executive Chair White Marvin L exercised/converted 1 Common Stock
- · Executive Chair White Marvin L exercised/converted 1,666 Common Stock
- · Executive Chair White Marvin L had withheld for taxes 406 Common Stock at $4.07 (~$1.65K)
- · Executive Chair White Marvin L exercised/converted 1 Restricted Stock Unit
- · Executive Chair White Marvin L exercised/converted 1,666 Restricted Stock Unit
10-08-2026
Director Abdun-Nabi Daniel exercised/converted 400 Common Stock. Abdun-Nabi Daniel holds 400 shares after the transaction.
- · Director Abdun-Nabi Daniel exercised/converted 400 Common Stock
- · Director Abdun-Nabi Daniel exercised/converted 400 Restricted Stock Unit
10-08-2026
Director Kunz Barbara Lopez exercised/converted 400 Common Stock. Kunz Barbara Lopez holds 400 shares after the transaction.
- · Director Kunz Barbara Lopez exercised/converted 400 Common Stock
- · Director Kunz Barbara Lopez exercised/converted 400 Restricted Stock Unit
10-08-2026
Director Albers Jeffrey W. sold 10,000 Common Stock at $104.68 (~$1.05M). 5 transactions reported in total. Albers Jeffrey W. holds 9,360 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Albers Jeffrey W. exercised/converted 5,000 Common Stock at $10.39 (~$52K)
- · Director Albers Jeffrey W. sold 5,000 Common Stock at $104.47 (~$522K)
- · Director Albers Jeffrey W. sold 8,000 Common Stock at $104.38 (~$835K)
- · Director Albers Jeffrey W. sold 10,000 Common Stock at $104.68 (~$1.05M)
- · Director Albers Jeffrey W. exercised/converted 5,000 Stock Option (Right to Buy)
10-08-2026
Apollo Management Holdings GP, LLC and related entities filed an amended Schedule 13G/A with the SEC on August 10, 2026, disclosing aggregate beneficial ownership of 12,128,756 shares of USA TODAY Co., Inc. common stock, representing 8.3% of the 146,817,941 shares outstanding as of August 3, 2026. The filing indicates passive investment intent, with no changes in control or influence. The largest holder among the group is Apollo Credit Strategies Master Fund Ltd. with 10,167,211 shares (6.9%), while other entities hold smaller stakes.
- · Apollo Credit Strategies Master Fund Ltd. holds 10,167,211 shares (6.9%), the largest single stake among the reporting entities.
- · Apollo Atlas Master Fund, LLC holds 213,903 shares (0.1%).
- · Apollo Credit Strategies Absolute Return Aggregator A, L.P. holds 953,507 shares (0.6%).
- · Apollo PPF Credit Strategies, LLC holds 794,135 shares (0.5%).
- · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.
- · All reporting persons disclaim beneficial ownership except for the shares they hold of record.
10-08-2026
Apollo Management entities disclosed beneficial ownership of 27,505,017 ADSs (representing 18.9% of shares outstanding) in Grupo Aeromexico, S.A.B. de C.V. as of June 30, 2026. The ADSs are primarily held directly by AP Aguila Holdings, Ltd. (24,285,302 ADSs), with an additional 3,219,715 ADSs held in trust by Banco Actinver on behalf of AP Aguila. The filing is a routine Schedule 13G/A amendment with no change in ownership from the prior filing, showing stable, flat position.
- · The filing is an amendment to Schedule 13G, indicating no change in aggregate beneficial ownership from prior filings.
- · AP Aguila's ADSs are subject to voting limits under Mexican Foreign Investment Law and the issuer's organizational documents.
- · Banco Actinver F/5292 Trust votes the Common Shares according to trust terms and Mexican banking regulations.
- · The issuer had 1,459,034,090 Common Shares (represented by 145,903,409 ADSs) outstanding as of April 15, 2026, per its 20-F filed April 30, 2026.
- · Apollo management entities collectively disclaim beneficial ownership and the filing is not an admission of beneficial ownership for Section 13(d) or 13(g) purposes.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G disclosing beneficial ownership of 1,162,936 Class A Ordinary Shares of Cal Redwood Acquisition Corp., representing 4.9% of the outstanding shares as of June 30, 2026. The filing indicates a passive investment stake held in the ordinary course of business, with no intent to change or influence control of the issuer.
- · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b), indicating passive investment intent.
- · Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, and is a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the companies.
- · The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
10-08-2026
Director Kotarba Scott bought 176,006 Obligation to Buy (Initial Purchase) at $1.85 (~$326K). 4 transactions reported in total. Kotarba Scott holds 100 shares after the transaction.
- · Director Kotarba Scott was awarded 100 Common Stock
- · Director Kotarba Scott bought 176,006 Obligation to Buy (Initial Purchase) at $1.85 (~$326K)
- · Director Kotarba Scott bought 176,006 Purchase Option (right to buy) at $1.85 (~$326K)
- · Director Kotarba Scott bought 386,522 Purchase Option (right to buy)
10-08-2026
President KREEGER SCOTT had withheld for taxes 143,841 CLASS A COMMON STOCK at $61.95 (~$8.91M). 6 transactions reported in total. KREEGER SCOTT holds 203,881 shares after the transaction.
- · President KREEGER SCOTT exercised/converted 46,400 CLASS A COMMON STOCK at $42.56 (~$1.97M)
- · President KREEGER SCOTT exercised/converted 128,600 CLASS A COMMON STOCK at $44.19 (~$5.68M)
- · President KREEGER SCOTT had withheld for taxes 143,841 CLASS A COMMON STOCK at $61.95 (~$8.91M)
- · President KREEGER SCOTT sold 31,159 CLASS A COMMON STOCK at $61.78 (~$1.92M)
- · President KREEGER SCOTT exercised/converted 46,400 EMPLOYEE STOCK OPTION (RIGHT TO BUY)
- · President KREEGER SCOTT exercised/converted 128,600 EMPLOYEE STOCK OPTION (RIGHT TO BUY)
10-08-2026
Conglin Deng, CEO and Chairman of Abits Group Inc (ABTS), sold his entire beneficial stake (approximately 47% voting power) to ARC Group International Ltd. on August 6, 2026, ceasing to be a >5% owner. The transaction includes a contingent right for Deng to receive either $5,000,000 in additional ordinary shares (if the company completes a business acquisition within 180 days) or $5,000,000 in cash otherwise.
- · The transaction closed on August 6, 2026, one day after the agreement date of August 5, 2026.
- · Deng retains a future subscription right to receive Additional Ordinary Shares valued at $5,000,000 if the Issuer completes a Business Acquisition within 180 days of closing.
- · If no Business Acquisition occurs within the Acquisition Period, the Purchaser must pay Deng $5,000,000 in cash within 30 days.
- · The number of Additional Ordinary Shares issuable is based on the lowest VWAP during the 10 consecutive trading days preceding announcement, definitive documents, or issuance date.
- · The filing is an amendment (No. 2) to Schedule 13D, indicating prior ownership disclosures.
10-08-2026
Apollo Management Holdings GP, LLC and related entities filed a Schedule 13G/A with the SEC on August 10, 2026, disclosing aggregate beneficial ownership of 11,859,526 shares of Community Health Systems Inc. common stock, representing 8.4% of the 141,009,357 shares outstanding as of July 16, 2026. The filing reflects a passive investment (Rule 13d-1(c)) by multiple Apollo-affiliated funds and management entities, with the largest direct holdings held by Apollo Credit Strategies Master Fund Ltd. (4,613,503 shares, 3.3%) and AAA Multi-Asset Credit Strategies Fund (Z), L.P. (789,447 shares, 0.6%).
- · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c), indicating a passive investment intent.
- · Apollo entities disclaim beneficial ownership of all shares reported, except for the specific funds that directly hold the securities.
- · The largest single holder among the Apollo entities is Apollo Credit Strategies Master Fund Ltd. with 4,613,503 shares (3.3%).
- · Apollo Atlas Master Fund, LLC holds only 50,263 shares, representing 0.0% of outstanding shares.
- · The filing date is August 10, 2026, with the event date as of June 30, 2026.
- · The total outstanding shares of Community Health Systems Inc. as of July 16, 2026, is 141,009,357, as per the company's Form 10-Q filed on July 23, 2026.
10-08-2026
Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC, reporting beneficial ownership of 82,259 common shares of Brazil Potash Corp., representing 0.1% of the outstanding shares as of June 30, 2026. The filing indicates a passive investment stance, with the securities held in the ordinary course of business and not for changing or influencing control of the issuer.
- · The filing is an amendment to Schedule 13G (SC 13G/A) filed on August 10, 2026.
- · The securities are held by Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, which is a subsidiary of The Goldman Sachs Group, Inc.
- · The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings.
- · Goldman Sachs disclaims beneficial ownership of securities held in client accounts or certain investment entities where it acts as general partner or manager.
10-08-2026
Apollo Principal Holdings A GP, Ltd. and affiliated entities filed a Schedule 13G/A disclosing beneficial ownership of 24,901,319 shares of Phoenix Education Partners, Inc. (PXED) common stock, representing a 69.1% stake as of June 30, 2026. The filing is an amendment to a prior Schedule 13G and reflects no change in the ownership level from the previous filing. The shares are held of record by AP VIII Socrates Holdings, L.P., with the other reporting persons disclaiming beneficial ownership.
- · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
- · The reporting persons disclaim beneficial ownership of the shares, except for AP VIII Socrates Holdings, L.P., which is the holder of record.
- · The ownership percentage is based on 36,047,376 shares outstanding as of July 7, 2026, per the issuer's Form 10-Q filed July 14, 2026.
- · The filing date is August 10, 2026, and the event date is June 30, 2026.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →August 11, 2026
USA Corporate Events Calendar — August 11, 2026
USA Corporate Events Calendar
August 11, 2026
USA Earnings Calls Schedule — August 11, 2026
USA Earnings Calls Schedule
August 10, 2026
US SEC Filings Daily Market Digest — August 10, 2026
US SEC Filings Daily Market Digest
August 10, 2026
S&P 500 Technology Sector SEC Filings — August 10, 2026
S&P 500 Technology Sector SEC Filings